跳至主要内容
临床试验/NCT00028977
NCT00028977已完成1 期

A Pilot Safety, Feasibility, Efficacy And Correlative (Phase I/II) Study Assessing Herba Scutellaria Barbatae (HSB) For Metastatic Breast Cancer

University of California, San Francisco4 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2001年8月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
21
试验地点
4

研究概览

简要总结

RATIONALE: The Chinese herb Scutellaria barbata contains ingredients that may slow the growth of cancer cells and may be an effective treatment for metastatic breast cancer.

PURPOSE: Phase I/II trial to study the effectiveness of Scutellaria barbata in treating women who have metastatic breast cancer.

详细描述

OBJECTIVES:

  • Determine the efficacy of Scutellaria barbata (Chinese herbal extract) in terms of tumor response in women with metastatic breast cancer.
  • Determine the safety and toxicity of this therapy in these patients.
  • Determine the feasibility of this therapy in these patients.
  • Determine the time to progression, overall survival, and resource utilization of patients treated with this therapy.
  • Determine the quality of life of patients treated with this therapy.
  • Determine the bioavailability and pharmacokinetics of this therapy in these patients.

OUTLINE: Patients receive oral Scutellaria barbata (Chinese herbal extract) twice daily for 12 months in the absence of disease progression or unacceptable toxicity.

Quality of life is assessed at baseline and then every 6 months thereafter.

PROJECTED ACCRUAL: A total of 25 patients will be accrued for this study.

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Herbal Therapy in Treating Women With Metastatic... | 临床试验